AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

KROPZ PLC

Declaration of Voting Results & Voting Rights Announcements Oct 17, 2024

7754_rns_2024-10-17_cd90dcd1-9ade-4eb4-afc0-c0ab9cc933f3.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4832I

Kropz PLC

17 October 2024

17 October 2024

Kropz plc

("Kropz" or the "Company")

Admission of Fundraising Shares

and

Total Voting Rights

Kropz plc (AIM: KRPZ), an emerging African phosphate producer, announces that the 643,873,018 new Ordinary Shares ("New Ordinary Shares") to be issued pursuant to the Fundraising will be admitted to trading on AIM ("Admission") and dealings in respect of the New Ordinary Shares will commence at 8.00 a.m. on 18 October 2024.

Following Admission, the Company's issued share capital will be 1,567,591,241   Ordinary Shares. This figure of 1,567,591,241   may then be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information visit   www.kropz.com  or contact:

Kropz Plc Via Tavistock
Louis Loubser (CEO) +44 (0) 207 920 3150
Grant Thornton UK LLP Nominated Adviser
Samantha Harrison 

Harrison Clarke 

Ciara Donnelly
+44 (0) 20 7383 5100
Hannam & Partners Broker
Andrew Chubb 

Ernest Bell
+44 (0) 20 7907 8500
Tavistock Financial PR & IR (UK)
Nick Elwes 

Jos Simson
+44 (0) 207 920 3150 

[email protected]
R&A Strategic Communications PR (South Africa)
Charmane Russell 

Marion Brower
+27 (0) 11 880 3924 

[email protected]  

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCQKABNPBDDOKD

Talk to a Data Expert

Have a question? We'll get back to you promptly.